Brief: Interpace Diagnostics Group Q3 Loss Per Share $0.11

Interpace Biosciences

13/11/2018 21:47

Interpace Diagnostics Group Inc  IDXG.O :
    * INTERPACE DIAGNOSTICS REPORTS THIRD QUARTER 2018 FINANCIAL
RESULTS, BUSINESS PROGRESS AND RECENT ACCOMPLISHMENTS
    * Q3 LOSS PER SHARE $0.11
    * Q3 REVENUE $5.8 MILLION VERSUS I/B/E/S VIEW $5.6 MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.07 -- THOMSON REUTERS
I/B/E/S
    * SEES FY 2018 REVENUE $21 MILLION TO $22 MILLION

Source text for Eikon:  ID:nGNX38T1lS 
Further company coverage:  IDXG.O